Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AFFLUENT MEDICAL | 18,796,659 | net | 02 Feb 2026 | tx 7+18,796,659 |
| ABIVAX | -638,488.088 | net | 02 Oct 2024 | tx 10+265,000−903,488.088 |
| CARBIOS | 130,054 | net | 13 Jul 2023 | tx 2+130,054 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | PURCHASE | AFFLUENT MEDICAL | 2,136,751 | 2.34 EUR | |
| 20 Oct 2025 | PURCHASE | AFFLUENT MEDICAL | 16,176 | 1.36 EUR | |
| 21 Jul 2025 | PURCHASE | AFFLUENT MEDICAL | 18,382 | 1.36 EUR | first after silence |
| 02 Oct 2024 | SALE | ABIVAX | 117,630 | 9.10 EUR | |
| 19 Sept 2024 | SALE | ABIVAX | 35,000 | 10.00 EUR | |
| 11 Sept 2024 | SALE | ABIVAX | 41,270 | 10.27 EUR | |
| 16 Jul 2024 | CONVERSION | AFFLUENT MEDICAL | 2,479,411 | 1.38 EUR | |
| 29 Jan 2024 | PURCHASE | AFFLUENT MEDICAL | 1,419,871 | 1.56 EUR | |
| 19 Dec 2023 | SALE | ABIVAX | 75,000 | 9.67 EUR | |
| 11 Dec 2023 | SALE | ABIVAX | 2,062 | 9.40 EUR | |
| 20 Oct 2023 | PURCHASE | ABIVAX | 265,000 | — | |
| 13 Jul 2023 | SALE | ABIVAX | 16.088 | 192781.00 EUR | |
| 13 Jul 2023 | SALE | ABIVAX | 192,781 | 16.09 EUR | |
| 13 Jul 2023 | PURCHASE | CARBIOS | 129,427 | 30.91 EUR | |
| 15 Jun 2023 | PURCHASE | CARBIOS | 627 | 39.92 EUR | |
| 08 Jun 2023 | SALE | ABIVAX | 224,729 | 17.22 EUR | |
| 06 Mar 2023 | PURCHASE | AFFLUENT MEDICAL | 6,363,034 | 1.32 EUR | |
| 06 Mar 2023 | PURCHASE | AFFLUENT MEDICAL | 6,363,034 | 0.03 EUR | |
| 06 Dec 2022 | SALE | ABIVAX | 215,000 | 6.23 EUR |
1 purchase reported after at least 12 months of silence — most recent on 21 Jul 2025.